The multi-target small-molecule inhibitor SB747651A shows in vitro and in vivo anticancer efficacy in glioblastomas
Abstract Glioblastoma multiforme is the most common primary brain tumor and among the most lethal types of cancer. Several mono-target small molecule-inhibitors have been investigated as novel therapeutics, thus far with poor success. In this study we investigated the anticancer effects of SB747651A...
Saved in:
Main Authors: | Arnon Møldrup Knudsen, Henning Bünsow Boldt, Elisabeth Victoria Jakobsen, Bjarne Winther Kristensen |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/eb0995e2ff9d49fc8f512f48a138a289 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
AN1-type zinc finger protein 3 (ZFAND3) is a transcriptional regulator that drives Glioblastoma invasion
by: Anne Schuster, et al.
Published: (2020) -
Small molecule inhibitor of OGG1 blocks oxidative DNA damage repair at telomeres and potentiates methotrexate anticancer effects
by: Juan Miguel Baquero, et al.
Published: (2021) -
9-ING-41, a small molecule inhibitor of GSK-3beta, potentiates the effects of anticancer therapeutics in bladder cancer
by: Hiroo Kuroki, et al.
Published: (2019) -
Case Report: Malignant Primary Sellar Paraganglioma With Unusual Genetic and Imaging Features
by: Stefan Stojanoski, et al.
Published: (2021) -
Antitheilerial Activity of the Anticancer Histone Deacetylase Inhibitors
by: Madhumanti Barman, et al.
Published: (2021)